Skip to main content

Freedman Lori's Form 4 filing

Organogenesis Holdings Inc. (ORGO) · filed Jun 6, 2025

Accession no.
0001062993-25-011161
Filed
Jun 6, 2025
Trade date
Jun 4-6, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $725.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Freedman LoriCIK 0001410291Officer (Chief Admin. and Legal Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 4, 2025Class A Common StockPPurchaseAcquired+100,863$2.82+$284,433.66695,058Direct
Jun 5, 2025Class A Common StockPPurchaseAcquired+142,379$2.91+$414,322.89837,437Direct
Jun 6, 2025Class A Common StockPPurchaseAcquired+9,022$2.99+$26,975.78846,459Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)